Product which does not conform to product requirements was not adequately identified and controlled to prevent its unintended use or delivery.
Inspection Record
BioSensics LLC — FDA 483 Findings
Inspectors James P FinnThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Corrective action was not adequately taken to eliminate the cause of nonconformities in order to prevent recurrence.
Design and development procedures were not adequately documented.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.